Dr. Karin Hatzold, M.D., MPH, is a public health physician with over 27 years of experience in researching, designing, and delivering public health interventions, including 24 years in southern Africa. Based in Cape Town, South Africa, Hatzold is the director for HIV, TB, and viral hepatitis at PSI and the project director of the Self-Testing Africa, or STAR, project. With deep experience in program design and management, policy development, and implementation research, Dr Hatzold has a proven track record in bringing new interventions from R&D through piloting to policy shift to scale across a range of health areas including HIV, TB, SRH, viral hepatitis, and Covid-19.

Dr. Kee Park is a neurosurgeon by training and serves as the director of policy and advocacy at the Harvard PGSSC.

Dr. Kelle Moley is a career physician-scientist obstetrician/gynecologist with over 35 years of experience in reproductive health. After leaving academia in 2018, Kelle became chief scientific officer at March of Dimes, and deputy director of reproductive health technologies at the Gates Foundation. Now, Kelle is Ferring’s vice president reproductive medicine and maternal health TA, including leading the Safe Birth project, to prevent postpartum hemorrhage in lower-income countries.

Dr. Khidir Dalouk is the advocacy director for the Sudanese American Physicians Association and a cardiac electrophysiologist based in Portland, Oregon, United States.

Dr. Krishna Udayakumar is the founding director of the Duke Global Health Innovation Center, focused on generating deeper evidence and support for the study, scaling, and adaptation of health innovations and policy reforms globally. He is also executive director of Innovations in Healthcare, a nonprofit co-founded by Duke, McKinsey & Company, and the World Economic Forum. He leads the organization’s work of curating and scaling the impact of transformative health solutions globally.

Dr. Laura Murray, a clinical psychologist, is a senior scientist at Johns Hopkins Bloomberg School of Public Health. Murray has extensive expertise in a wide range of evidence-based treatments, including training, implementation, and evaluation. She has conducted evaluations ranging from qualitative understanding of mental/behavioral health, to full randomized trials of treatments all over the world, working with numerous health sectors. She has a passion for innovating new solutions to improve service quality and delivery with a systems approach. Murray publishes extensively in top journals, trains globally, regularly speaks at conferences and organizations, and consults with organizations on skills-training for stress, resilience, and leadership.

Dr. Lucica Ditiu is the executive director of the Stop TB Partnership. She is a Romanian physician, accomplished professional, and leader in the global fight against tuberculosis and other communicable diseases. Ditiu is driven by the firm belief that we should "leave no one behind" and is one of the strongest advocates within the international community in the fight against tuberculosis. A believer in innovation, flexibility, change, breaking the rules and thinking out of the box, Ditiu is dedicated to driving political commitment and engagement to accelerate the efforts to end TB.

Global Health President Dr. Lutz Hegemann is responsible for integrating global health and environmental, social, and governance matters into the core of the Novartis business. This includes our global health programs in communicable and noncommunicable diseases, our business in sub-Saharan Africa as well as the Novartis Foundation. Since joining Novartis in the Consumer Health Division in 2005, Hegemann held roles of increasing responsibility. He began his career as a public health physician and scientist.

Dr. Magda Robalo is the UHC2030 co-chair and interim executive director of Women in Global Health. A visionary leader in global health, she has spearheaded successful initiatives as president and co-founder of the Institute for Global Health and Development, former minister of health of Guinea-Bissau, and senior positions in the World Health Organization Africa region.

Dr. Mamka Anyona is the policy and strategy lead for the U.N. multipartner trust fund for noncommunicable diseases and mental health. She is a global health expert with a decade of experience in the prevention and management of chronic diseases through systems transformation.